HistoWiz is a Y Combinator (W16) and Zhenfund backed biotechnology company that automates histopathology for biomedical researchers in academia and the pharmaceutical industry. Its intelligent tissue platform facilitates collaboration between scientists and clinicians, and gives pathologists cutting edge tools to diagnose cases digitally, saving valuable time and resources. The company’s mission is to fight cancer cooperatively instead of individually. We are the largest and fastest cloud histology company with a $2.5M revenue run rate and we are cash flow positive. Our vision is to combine biology with computer science and bring cutting-edge technologies to biomedical researchers. Since our inception in 2013, we've acquired 1500+ paying customers from top academic institutions and pharmaceutical companies around the world, including Sloan Kettering, Cornell, Stanford, Harvard, Dana Farber, MD Anderson, HHMI, Janssen, Regeneron, Shire, Novo Nordisk. We already have accumulated th...